Rifampin use in peritoneal dialysis.
Zimmerman
S W
SW
Johnson
C A
CA
D000900:Anti-Bacterial Agents; D002408:Catheters, Indwelling; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D012293:Rifampin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D012293:Rifampin